Sally L. Stephenson
- Epidemiology top 1%
- Hepatology top 0.5%
- Infectious Diseases top 5%
- Oncology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- A J KennyDF GrayChing‐Lung LaiDar‐In TaiRong‐Nan ChienRichard GuanPui–Chee WuTing‐Tsung Chang
- Topics
- Peptidase Inhibition and Analysis (5 papers)Neuropeptides and Animal Physiology (4 papers)Protein Hydrolysis and Bioactive Peptides (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Sally L. Stephenson
10 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Epidemiology 2.0k
- Hepatology 1.9k
- Infectious Diseases 449
- Oncology 415
- Cardiology and Cardiovascular Medicine 289
Countries citing papers authored by Sally L. Stephenson
This map shows the geographic impact of Sally L. Stephenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally L. Stephenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally L. Stephenson more than expected).
Fields of papers citing papers by Sally L. Stephenson
This network shows the impact of papers produced by Sally L. Stephenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally L. Stephenson. The network helps show where Sally L. Stephenson may publish in the future.
Co-authorship network of co-authors of Sally L. Stephenson
This figure shows the co-authorship network connecting the top 25 collaborators of Sally L. Stephenson. A scholar is included among the top collaborators of Sally L. Stephenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally L. Stephenson. Sally L. Stephenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Histological outcome during long-term lamivudine therapybreakdown → | 583 |
| 2 | A One-Year Trial of Lamivudine for Chronic Hepatitis Bbreakdown → | 1427 |
| 3 | 64 | |
| 4 | 61 | |
| 5 | 1 | |
| 6 | 164 | |
| 7 | 43 | |
| 8 | 242 | |
| 9 | 146 | |
| 10 | 99 |
About Sally L. Stephenson
Sally L. Stephenson is a scholar working on Hepatology, Oncology and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 2.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Neuropeptides and Animal Physiology (4 papers) and Protein Hydrolysis and Bioactive Peptides (2 papers). The work is most often cited by research in Hepatology (1.9k citations), Epidemiology (2.0k citations) and Infectious Diseases (449 citations). Sally L. Stephenson has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include A J Kenny, DF Gray, Ching‐Lung Lai, Dar‐In Tai, Rong‐Nan Chien, Richard Guan, Pui–Chee Wu, Ting‐Tsung Chang, Nancy W.Y. Leung and Judy Barber. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.